pfizer glp-1 pipeline has released promising mid-stage Phase IIb trial data for its obesity treatment, PF-3944. This long-acting injectable demonstrated an impressive 12.3% placebo-adjusted weight loss at 28 weeks with monthly dosing, positioning Pfizer Acquires Metsera for $4.9
Pay in 4 interest-free payments of $5.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25





























![Doom Dozer [GLD1-EN025] Common P-007](https://cdn.shopify.com/s/files/1/0757/5211/2443/products/e52360e3-18bf-5c09-b33b-367503f8279b.png?v=1683345022)